A review of the rationale for the testing of the calcineurin inhibitor tacrolimus for post-ERCP pancreatitis prevention
Monique T. Barakat, Asna Khalid, Mang Yu, Ying Ding, Judy‐April Murayi, Thottala Jayaraman, Ronald Poropatich, Venkat Akshintala, Wassem Juakiem, Li Wen, Georgios I. Papachristou, Sohail Z. Husain
Topics & Concepts
MedicineCalcineurinTacrolimusEndoscopic retrograde cholangiopancreatographyPancreatitisAdverse effectGastroenterologyPharmacologyInternal medicineTransplantationGallbladder and Bile Duct DisordersPediatric Hepatobiliary Diseases and TreatmentsPancreatitis Pathology and Treatment